BlueSphere Bio
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
350 Technology Dr Ste 510, Pittsburgh, P...Phone Number
(412) 368-3007Website
www.bluespherebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About BlueSphere Bio
BlueSphere Bio is focused on developing novel TCR-based therapies aimed at treating hematologic malignancies, solid tumors, and rare diseases. The company's vision is to ensure that every cancer patient has a chance for a cure. Their clinical programs include therapies such as TCX-101 and TCX-102. BlueSphere Bio is dedicated to advancing cancer treatment through innovative technology and research.Explore more
BlueSphere Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BlueSphere Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on BlueSphere Bio recently announced quarterly report
Funding: Get notified immidiatlly once BlueSphere Bio has new funding data
Check if BlueSphere Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when BlueSphere Bio launches new products
BlueSphere Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at BlueSphere Bio
Check out if BlueSphere Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BlueSphere Bio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at BlueSphere Bio
Find 3 more new buyers
Compare Similar Companies to BlueSphere Bio
Compare insights from companies similar to BlueSphere Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$6.5M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
BlueSphere Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BlueSphere Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BlueSphere Bio.
BlueSphere Bio financials insights
Gather financial insights about BlueSphere Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series B
$45M
BlueSphere Bio Tech Stack
A closer look at the technologies used by BlueSphere Bio
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Person-Based
BlueSphere Bio News & Media
BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
Seasoned executive brings more than three decades of immunotherapy and drug discovery experience Seasoned executive brings more than three decades of immunotherapy and drug discovery experienceCelularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company
Leverages Celularity World-class Manufacturing Capabilities Leverages Celularity World-class Manufacturing CapabilitiesBlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS
BlueSphere accepted as a virtual member of Johnson & Johnson Innovation – JLABS, a premier global network of health incubators BlueSphere accepted as a virtual member of Johnson & Johnson Innovation – JLABS, a premier global network of health incubatorsBlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
PITTSBURGH, June 25, 2024 (GLOBE NEWSWIRE) -- BlueSphere Bio, a drug development company focused on novel T-cell receptor (TCR) based therapies for oncology and non-oncology indications, today announced a collaboration with NMDP BioTherapies℠ (formerly Be The Match BioTherapies), an organization offering solutions for companies developing and commercializing cell and gene therapies, to advance BlueSphere’s first clinical trial evaluating a novel cell therapy for patients with high-risk leukemias
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BlueSphere Bio
Sign Up For FreeTo access detailed company insights
BlueSphere Bio is focused on developing novel TCR-based therapies aimed at treating hematologic malignancies, solid tumors, and rare diseases. The company's vision is to ensure that every cancer patient has a chance for a cure. Their clinical programs include therapies such as TCX-101 and TCX-102. BlueSphere Bio is dedicated to advancing cancer tre... Read More
